These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 29251166

  • 1. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
    Yabushita T, Satake H, Maruoka H, Morita M, Katoh D, Shimomura Y, Yoshioka S, Morimoto T, Ishikawa T.
    Leuk Lymphoma; 2018 Sep; 59(9):2144-2151. PubMed ID: 29251166
    [Abstract] [Full Text] [Related]

  • 2. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
    Paprocka M, Bielawska-Pohl A, Rossowska J, Krawczenko A, Duś D, Kiełbiński M, Haus O, Podolak-Dawidziak M, Kuliczkowski K.
    Eur J Haematol; 2017 Nov; 99(5):415-422. PubMed ID: 28805931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia.
    Wang J, Lai ZL, Chen XY, Li DY, Zhang YY, Ma W, Chu YT, Shi FQ, Yang L, Hou L.
    Chin J Integr Med; 2016 Jun; 22(6):438-44. PubMed ID: 26666761
    [Abstract] [Full Text] [Related]

  • 5. CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).
    Jiang Y, Xu P, Yao D, Chen X, Dai H.
    Med Sci Monit; 2017 Apr 09; 23():1725-1732. PubMed ID: 28391288
    [Abstract] [Full Text] [Related]

  • 6. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S, Rosenberger A, Quehenberger F, Krisper N, Prietl B, Reinisch A, Zebisch A, Sill H, Wölfler A.
    Cancer Med; 2019 Apr 09; 8(4):1771-1778. PubMed ID: 30848055
    [Abstract] [Full Text] [Related]

  • 7. [Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia].
    Yao DD, Han BQ, Han YF, Zhang YQ, Jin YL, Dai HB.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec 09; 26(6):1583-1588. PubMed ID: 30501688
    [Abstract] [Full Text] [Related]

  • 8. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H.
    Arch Med Res; 2014 May 09; 45(4):343-50. PubMed ID: 24751333
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F, Al-Mudallal SS.
    Cardiovasc Hematol Disord Drug Targets; 2020 May 09; 20(2):145-151. PubMed ID: 31438833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S, Ghaffari SH, Shaiegan M, Zarif MN, Nikbakht M, Akbari Birgani S, Alimoghadam K, Ghavamzadeh A.
    Life Sci; 2016 May 01; 152():190-8. PubMed ID: 27063991
    [Abstract] [Full Text] [Related]

  • 15. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C, Lenormand B, Bastard C, Boulet D, Lesesve JF, Callat MP, Stamatoullas A, Monconduit M, Tilly H.
    Am J Hematol; 1996 Nov 01; 53(3):175-80. PubMed ID: 8895688
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
    Aref S, Azmy E, El Ghannam D, Haroun M, Ibrahim L, Sabry M.
    Cancer Biomark; 2020 Nov 01; 29(1):9-16. PubMed ID: 32417762
    [Abstract] [Full Text] [Related]

  • 18. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.
    Gönen M, Sun Z, Figueroa ME, Patel JP, Abdel-Wahab O, Racevskis J, Ketterling RP, Fernandez H, Rowe JM, Tallman MS, Melnick A, Levine RL, Paietta E.
    Blood; 2012 Sep 13; 120(11):2297-306. PubMed ID: 22855599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.